HomeTipranavirTipranavir + Raltegravir

Does Tipranavir Interact with Raltegravir?

Tipranavir and Raltegravir have a moderate drug interaction according to U.S. FDA drug labeling data. No dose adjustment required for ISENTRESS, but coadministration not recommended for ISENTRESS HD. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Moderate
Tipranavir Class
Protease Inhibitor
Management
Monitor for effects
Data Source
U.S. FDA via OpenFDA

What To Tell Your Doctor or Pharmacist

If you are taking Tipranavir and your doctor is considering prescribing Raltegravir (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Tipranavir+💊 Raltegravir

Severity & Interaction Details

🟡
moderate
Be aware — moderate interaction
Documented interaction with manageable risk. May require dose adjustment or monitoring.
Severity scale
MinorContra
On record
Yes
Drug A class
Protease Inhibitor
Drug B class
Source
NLP:raltegravir

What this means in plain English

No dose adjustment required for ISENTRESS, but coadministration not recommended for ISENTRESS HD.

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Tipranavir and Raltegravir against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.